📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
💰 Capital Raise
55%
• Critical: only 0.7 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$2.52M
Shares Outstanding16.81B
FloatN/A
Cash$9.7K
Debt$309.9K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest329.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for GEGP
📊 GEGP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GEGP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.